Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.

Among the trends in the report are a growing proportion of younger adults with HF and worsening of racial disparities.

Most of our top stories this month stemmed from the ESC Congress—a mix of drug and device trials as well as guidelines.

Cardia Ltd., a global leader in the development of leaflet modification solutions for treating heart valves, announced today that the United States Food and Drug Administration (FDA) provided market ...

The findings were particularly pronounced in individuals with dementia, pointing to a possible vascular benefit of higher BP.

The continuing rise in global stroke burden indicates that approaches to managing the problem need to change, including by ...

We've been talking about it for decades, but we haven't seen the progress that we really want to see,” Vijay Kunadian says.

Referrals to cardiac rehab are too rare and risk factor control is poor, with striking variation between sexes and among ...

Inspired by the drive and innovation within intervention, this fellow is also passionate about prevention.

With patients surviving longer, there is a need to address long-term risks of CVD associated with cancer, say experts.

Stepwise, perioperative cardiac screening can help clinicians decide when to proceed with surgery or pause for more testing.

The stories of radiation- and lead-related injuries and illnesses are important for younger cardiologists to hear, those ...